Author

Dave L. Dixon

h-index 11 View on Semantic Scholar

We have 2 of 26 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways.

Optimal hypertension management requires not only stringent blood pressure control but also concomitant management of related cardiovascular, metabolic, and kidney comorbidities. Emerging evidence demonstrates that contemporary therapies improve albuminuria, estimated glomerular filtration rate trajectory, kidney outco...

Sriram Sriperumbuduri, Rachel W. Khan, Soyeb Aftab et al. · American Journal of Hyperten... · 0 citations

Review Jul 2026

Olezarsen and Plozasiran: Novel apoC-III targeting medications for the treatment of hypertriglyceridemia.

Overall, both olezarsen and plozasiran appear generally well tolerated, although monitoring of liver enzymes and glycemic control is warranted for both agents, and additional monitoring of platelet counts for olezarsen.

Michael S Kelly, Jelena Lewis, Dylan Zuch et al. · Journal of Cardiovascular Ph... · 0 citations